Erste Group analyst Hans Engel upgraded Johnson & Johnson to Buy from Hold. The firm, which notes that J&J has a higher operating margin and return on equity than its competitors, expects the stock price to rise further in the medium term given the company’s improved growth prospects.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Pacira collabs with J&J’s MedTech to expand market reach of ZILRETTA
- Johnson & Johnson Reports Strong Earnings Growth
- Johnson & Johnson Stock (JNJ) Bulls Target Breakout Despite Looming Patent Cliff
- Johnson & Johnson’s Earnings Call Highlights Growth and Challenges
- Roth MKM medical technology analyst holds analyst/industry conference call